Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2
- PMID: 11296270
- PMCID: PMC33181
- DOI: 10.1073/pnas.091537598
Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2
Abstract
We have previously described how T and natural killer (NK) lineage commitment proceeds from common T/NK progenitors (p-T/NK) in the murine fetal thymus (FT), with the use of a clonal assay system capable of discriminating p-T/NK from unipotent T or NK lineage-committed progenitors (p-T and p-NK, respectively). The molecular mechanisms controlling the commitment processes, however, are yet to be defined. In this study, we investigated the progenitor activity of FT cells from Id2-/- mice that exhibit defective NK cell development. In the Id2-/- FT, NK cells were greatly reduced, and a cell population that exclusively contains p-NK in the wild-type thymus was completely missing. Id2-/- FT progenitors were unable to differentiate into NK cells in IL-2-supplemented-FT organ culture. Single progenitor analysis demonstrated that all Id2-/- fetal thymic progenitors are destined for the T cell lineage, whereas progenitors for T/NK, T, and NK cell lineages were found in the control. Interestingly, the total progenitor number was similar between Id2-/- and Id2+/+ embryos analyzed. Expression of Id2 was correlated with p-NK activity. Our results suggest that Id2 is indispensable in thymic NK cell development, where it most probably restricts bipotent T/NK progenitors to the NK cell lineage.
Figures
Similar articles
-
Forced expression of Id2 in fetal thymic T cell progenitors allows some of their progeny to adopt NK cell fate.Int Immunol. 2007 Oct;19(10):1175-82. doi: 10.1093/intimm/dxm085. Epub 2007 Aug 14. Int Immunol. 2007. PMID: 17698981
-
Synergy between IL-15 and Id2 promotes the expansion of human NK progenitor cells, which can be counteracted by the E protein HEB required to drive T cell development.J Immunol. 2010 Jun 15;184(12):6670-9. doi: 10.4049/jimmunol.0901508. Epub 2010 May 10. J Immunol. 2010. PMID: 20483740
-
Regulation of NK1.1 expression during lineage commitment of progenitor thymocytes.J Immunol. 1998 Dec 15;161(12):6544-51. J Immunol. 1998. PMID: 9862680
-
In vivo function of a differentiation inhibitor, Id2.IUBMB Life. 2001 Apr;51(4):207-14. doi: 10.1080/152165401753311744. IUBMB Life. 2001. PMID: 11569914 Review.
-
The intrathymic crossroads of T and NK cell differentiation.Immunol Rev. 2010 Nov;238(1):126-37. doi: 10.1111/j.1600-065X.2010.00960.x. Immunol Rev. 2010. PMID: 20969589 Review.
Cited by
-
Differential requirement for Hoxa9 in the development and differentiation of B, NK, and DC-lineage cells from Flt3+ multipotential progenitors.BMC Immunol. 2013 Jan 30;14:5. doi: 10.1186/1471-2172-14-5. BMC Immunol. 2013. PMID: 23363389 Free PMC article.
-
Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR signaling.Nat Immunol. 2012 Feb 5;13(3):264-71. doi: 10.1038/ni.2230. Nat Immunol. 2012. PMID: 22306690 Free PMC article.
-
Combination of Asiatic Acid and Naringenin Modulates NK Cell Anti-cancer Immunity by Rebalancing Smad3/Smad7 Signaling.Mol Ther. 2018 Sep 5;26(9):2255-2266. doi: 10.1016/j.ymthe.2018.06.016. Epub 2018 Jun 22. Mol Ther. 2018. PMID: 30017880 Free PMC article.
-
Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue-inducer cell and NK cell lineages.Nat Immunol. 2010 Oct;11(10):945-52. doi: 10.1038/ni.1930. Epub 2010 Sep 5. Nat Immunol. 2010. PMID: 20818394 Free PMC article.
-
Natural Killer Cells: Development, Maturation, and Clinical Utilization.Front Immunol. 2018 Aug 13;9:1869. doi: 10.3389/fimmu.2018.01869. eCollection 2018. Front Immunol. 2018. PMID: 30150991 Free PMC article. Review.
References
-
- Williams N S, Klem J, Puzanov I J, Sivakumar P V, Schatzle J D, Bennett M, Kumar V. Immunol Rev. 1998;165:47–61. - PubMed
-
- Carlyle J R, Zuniga-Pflucker J C. Immunol Rev. 1998;165:63–74. - PubMed
-
- Spits H, Blom B, Jaleco A C, Weijer K, Verschuren M C M, van Dongen J J M, Heemskerk M H M, Res P C M. Immunol Rev. 1998;165:75–86. - PubMed
-
- Rodewald H R, Moingeon P, Lucich J L, Dosiou C, Lopez P, Reinherz E L. Cell. 1992;69:139–150. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
